Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Short term Debt (2015 - 2023)

Medpace Holdings' (MEDP) quarterly Short term Debt came in at $55.0 million in Q2 2023, down 77.97% on a YoY basis from $249.7 million in Q2 2022, and down 52.17% quarter-over-quarter from $115.0 million in Q1 2023.

Analysis

Medpace Holdings (MEDP) Short term Debt (2015 - 2023) Analysis & Trends

Medpace Holdings (MEDP) has reported Short term Debt for 6 consecutive years, with $55.0 million the latest figure, recorded in Q2 2023.

  • For the quarter ending Q2 2023, Short term Debt fell 77.97% year-over-year to $55.0 million; the trailing twelve-month figure through Jun 2023 stood at $55.0 million (down 77.97% YoY), and the FY2022 full-year result was $50.0 million, changed N/A from the prior year.
  • Short term Debt fell to $55.0 million in Q2 2023 per MEDP's latest filing, from $115.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $249.7 million in Q2 2022 and bottomed at $50.0 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 55.00 Mn
Mar 31, 2023 115.00 Mn
Dec 31, 2022 50.00 Mn
Sep 30, 2022 139.70 Mn
Jun 30, 2022 249.70 Mn
Jun 30, 2018 16.50 Mn
Mar 31, 2018 16.50 Mn
Dec 31, 2017 16.50 Mn
Sep 30, 2017 15.47 Mn
Jun 30, 2017 14.44 Mn
Mar 31, 2017 13.41 Mn
Dec 31, 2016 12.38 Mn
Dec 31, 2015 59,000.00